Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
In the absence of drugs to treat or prevent COVID-19, drug repurposing can be a valuable strategy. Despite a substantial number of clinical trials, drug repurposing did not deliver on its promise. While success was observed with some repurposed drugs (e.g., remdesivir, dexamethasone, tocilizumab, ba...
Saved in:
Main Author: | Assmus F. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/84934 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
COVID-19: Potential Repurposing Drugs
by: Wattana Leowattana
Published: (2022) -
COVID-19: Potential Repurposing Drugs
by: Leowattana W.
Published: (2023) -
Drug repurposing of N-acetyl cysteine as antiviral against dengue virus infection
by: Gopinathan Pillai Sreekanth, et al.
Published: (2020) -
Drug repurposing of quinine as antiviral against dengue virus infection
by: Shilu Malakar, et al.
Published: (2019) -
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
by: Ng, Yan Ling, et al.
Published: (2022)